bitBiome Closes Oversubscribed Seed Extension Round

May 26, 2026
Tokyo and Palo Alto-based biotechnology company bitBiome has closed an oversubscribed seed extension round, bringing its total equity and non-dilutive funding to over 45 million USD. The company plans to expand its microbial enzyme discovery and engineering platforms and strengthen its global partnerships.

bitBiome has closed an oversubscribed seed extension round, announced in a press release. The Tokyo and Palo Alto-based company stated that this latest funding brings its total equity and non-dilutive financing, including grants, to more than 45 million USD.

The new capital will support bitBiome's efforts to accelerate microbial enzyme and pathway discovery and engineering at scale. The company uses a combination of its proprietary single-cell microbial genome sequencing technology, a growing microbial gene database, and AI-based modeling and predictive tools to develop bio-based products.

bitBiome said it will use the funds to expand its global presence and deepen collaborations across industrial biotechnology, pharmaceuticals, synthetic biology, and biomanufacturing. Investors in the round include IQT, IT-Farm, Valuence Ventures, and Darwin Ventures.

The company’s technology platforms, bit-MAP, bit-GEM, and bit-EVO, enable genome analysis, enzyme discovery, and strain engineering. These systems are designed to transform microbial biodiversity into commercially viable solutions for the bioeconomy.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

05/26
JobsOhio Expands AI Ready Ohio Program to Train Thousands Statewide
05/26
OpenTug and Telegraph Partner to Connect Barge and Rail Freight Visibility
05/26
Kleinschmidt Acquires eBase Solutions to Expand Enterprise Integration Capabilities
05/26
Qlik Appoints Saugata Saha as Chief Executive Officer
05/26
Rokt Names Sam Dozor Chief Technology Officer

More from: Life Sciences

05/26
Brain Navi Introduces NaoTrac Surgical Robot for Precision Neurosurgery
05/26
Neurophet and VHIR Begin Joint Study on AI Imaging for Multiple Sclerosis
05/26
Insilico Medicine and Human Longevity Partner on AI Foundation Model for Longevity Science
05/26
Deerborne Group to Attend ASCO 2026 and Highlight AI Platform COMPASS 360
05/26
Parkinson's Foundation Identifies 2,000 Participants for Neuron23 Trial Through PD Trial Navigator

Subscribe to AI Funding Brief

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like